More About Us!

>> We recently updated our brochure about Highland Ophthalmology Vision Care Facility in New Windsor. Click here to view and print a copy!


>> Article Written by Dr. Mary Davidian "Amniotic Membrane For Ocular Inflammation" Ophthalmology Management, June 1, 2013


Highland Ophthalmology Associates Offering New FDA-Approved Avedro Corneal Collagen Cross-Linking Procedure to Keratoconus Patients

Highland Ophthalmology Establishes a Dry Eye Center of Excellence in the Hudson Valley of New York

>> Medical Eye Specialist Dr. Julia Mathews Joins New Windsor, New York Practice Highland Ophthalmology

Highland Ophthalmology Introduces LipiFlow to Address Dry Eye Syndrome Caused by MGD

Medical Eye Specialist Dr. Michael Stagner Joins New Windsor, New York Practice Highland Ophthalmology

>> Dr. Mary Davidian to Appear on American Health Front Program on NBC

>> Need for Eye Surgery Lessened by New Corneal Wound and Healing Treament

>> Highland Ophthalmology Opens New State-of-the-Art Vision Center

>> Highland Ophthalmology Celebrates Grand Opening of New Vision Center in New Windsor

>> Newburgh Ophthalmologists Offer Free Glaucoma Screenings Jan. 24

>> High-Tech Eye Care Right Here at Home

>> Eye Doctors Urge Exams During Glaucoma Awareness Month

>> Glaucoma Specialist Joins New Windsor, NY Ophthalmology Practice

>> New Windsor, NY Eye Surgeon Offers Alcon’s AcrySof® ReSTOR® Intraocular Lens for Cataract Correction

>> Alcon Launches AcrySof® ReSTOR® Apodized Diffractive IOL; Revolutionary Apodized Diffractive Technology Provides Highest Level of Freedom from Glasses

>> CMS Ruling Provides Medicare Patients Access to Alcon’s AcrySof® ReSTOR® IOL


HOA Procedures

Glaucoma Treatment

Glaucoma is a disorder associated with pressure in the eye, and is characterized by damage to the optic nerve. Glaucoma affects 3 million Americans, and half of those people are unaware they have the disease.

Approximately 5 to 10 million Americans have elevated eye pressure, which places them at risk for the development of glaucoma. Eighty thousand Americans are already blind from the disease. Overall, glaucoma occurs in two out of every 100 people. The risk factors for glaucoma increase for people over the age of 60, African Americans over the age of 40, people with a family history of glaucoma and anyone that has had a previous serious eye injury. If you are at risk you should have your eyes examined. Glaucoma usually does not cause symptoms, so most people with glaucoma are unaware that they have it.

For those patients diagnosed with Glaucoma, a treatment and follow-up plan will be organized. The goal of glaucoma therapy is to preserve the patients present level of vision, i.e., to prevent further peripheral, and sometimes central, vision loss. The treatment plan will vary widely depending on the type of glaucoma diagnosed, the degree to which the glaucoma has progressed, the patients underlying risk factors, and many other variables which are beyond the scope of this brief overview. In general, medicine (both topical eye-drops and oral medications), laser procedures, and operative procedures are all utilized in order to preserve vision.

Patients are followed at variable intervals according to the severity of glaucoma disease and response to treatment. However, most patients will be evaluated 2 to 4 times a year with pressure measurements, optic nerve evaluations, and visual field testing. In some cases, despite the most meticulous care and aggressive management, patients will continue to lose vision. However, in the majority of cases in which patients are diagnosed early in the course of their disease and are compliant with the ophthalmologists advice, useful vision can be maintained throughout life.

Glaucoma is much more complex than most patients would like to believe. This very fact is the reason that glaucoma sub-specialist ophthalmologists have an additional one to two years of fellowship training beyond the four years of general ophthalmology residency training. That's why it is very important to choose a doctor with experience that you can trust for your glaucoma management.

Our office is within an easy commute from the following areas in the Hudson Valley and Orange County and Dutchess County: New Windsor, Cornwall, Fishkill, Middletown, Florida, Warwick, Monroe, Harriman, Fort Montgomery, Highland Falls, Marlboro, Walden, Wallkill, Pine Bush, Vails Gate, Goshen, Salisbury Mills, Washingtonville, Campbell Hall, Montgomery, West Point, Modena, New Paltz, Highland, Beacon, Castle Point, Wappingers Falls, Poughkeepsie, NY.

With this, Highland Ophthalmology has become New Windsor's leading specialty eye care center. Call (845) 562-0138 today for your first consultation.

Highland Ophthalmology Associates on LinkedIn



To expedite your visit to Highland Ophthalmology please download and complete a New Patient Information Form prior to your first visit and present it to the receptionist when checking in:

Contact Us

Call us at (845) 562-0138 or fill out and submit this form to learn more about Highland Ophthalmology.

Please Note: Do not use this form for emergency purposes.

* Required Fields

I agree to the Terms of Use
and Privacy Policy.

By checking the box, you are indicating that you have read, understand and consent to Highland Ophthalmology Associates Terms of Use and Privacy Policy.


AcrySof® IQ Toric IOLs


AcrySof® IQ ReSTOR® IOLs







TearLab® Osmolarity System


Copyright © 2017
Highland Ophthalmology Associates, LLC.
All rights reserved.

140 Executive Drive
New Windsor, NY 12553

Telephone (845) 562-0138
Fax (845) 562-0147

To see a map of our location and get directions, click here.

About HOA Procedures

Dr. Mary Davidian
Dr. Thien Huynh
Dr. Julia Mathew
Dr. Sharon Bean Powell

Cataract Treatment
Corneal Transplants
Glaucoma Treatment
Dry Eye Treatment